This Medical News article discusses how the FDA’s new authority over e-cigarettes could affect adult smoking cessation.
This JAMA Clinical Guidelines Synopsis summarizes the US Preventive Services Task Force’s 2015 guideline on screening for tobacco smoking and provision of cessation interventions.
This Recommendation Statement from the US Preventive Services Task Force recommends against screening for chronic obstructive pulmonary disease in asymptomatic adults.
This randomized trial compares the efficacy of varenicline, nicotine patch, and combination nicotine replacement therapy (patch plus lozenges) on smoking abstinence at 26 weeks among adults interested in quitting smoking.
This editorial interprets a JAMA Internal Medicine randomized trial comparing durations of long-term nicotine patch treatment in the context of prior research evaluating smoking cessation treatments.
Ebbert and coauthors determine efficacy and safety of varenicline among 1510 cigarette smokers for increasing smoking abstinence rates through smoking reduction.
Rigotti and coauthors report the results from a randomized clinical trial on the effect of a sustained care intervention on postdischarge smoking cessation among hospitalized adults.
Koegelenberg and coauthors investigated the efficacy and safety of combining varenicline and a nicotine patch vs varenicline alone in smoking cessation through a randomized, blinded, placebo-controlled clinical trial that included 435 participants from 7 centers in South Africa.
To examine associations between tobacco use and mental illness, Cook and coauthors used nationally representative surveys of noninstitutionalized US residents to compare trends in smoking rates between adults with and without mental illness and to compare rates of smoking cessation among adults with mental illness who did and did not receive mental health treatment.